📰 Development Command News
Page 6 - Development Command News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Development Command. Real-time updates on events, politics, business and more.
January 3, 2024
The goal of the research is to identify the prevalence of chronic ankle pain after a lateral ankle sprain and examine its relationship with healthcare utilization patterns, subsequent musculoskeletal injury and the development of new co-comorbidities.
January 3, 2024
Three medical evacuation pilots at the U.S. Army Medical Research and Development Command’s Aeromedical Research Laboratory are mentors for aeromedical evacuation officers, which the Army designates as 67 Juliets, or
January 1, 2024
More than 200 military veterans and active duty members released an open letter on January 1 in which they vowed to do everything in their power to hold senior military leaders responsible for forcing the COVID-19 vaccine mandate on troops.
January 1, 2024
/PRNewswire/ -- Vivacelle Bio, a late-stage biopharma company developing life-saving treatments for shock and trauma, today announced that Cuthbert Simpkins...
December 28, 2023
28.12.2023 - Awarded additional $6.7 million to advance NexoBrid as a non-surgical field care solution; R&D project budget increased to $14.4 millionYAVNE, Israel, Dec. 28, 2023 (GLOBE NEWSWIRE) - MediWound Ltd. (Nasdaq: MDWD), a fully-integrated ... Seite 1
December 28, 2023
Awarded additional $6.7 million to advance NexoBrid as a non-surgical field care solution; R&D project budget increased to $14.4 millionYAVNE, Israel, Dec. 28, 2023 -- MediWound Ltd. , a...
December 28, 2023
Biopharmaceutical company MediWound Ltd (NASDAQ: MDWD) reported that the U.S.
December 28, 2023
Biopharmaceutical company MediWound Ltd (NASDAQ:MDWD) reported that the U.S. Department of Defense (DoD), through the Medical Technology...
December 28, 2023
YAVNE, Israel, Dec. 28, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-generation enzymatic therapeutics for tissue repair, today announced that the U.S. Department
December 6, 2023
Take a look into the profile of Brigadier General John M. Cushing, which makes him a pivotal executive for the 10th Annual Defense R&D Summit.